UNITED ~~STATES~~STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

SECURITIESFORM AND EXCHANGE COMMISSION 8-K

~~WASHINGTON,~~CURRENT ~~D.C. 20549~~ REPORT

~~FORM~~Pursuant ~~8-K~~to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~CURRENT~~Date ~~REPORT~~of Report (Date of earliest event reported): April 14, 2026

~~Pursuant~~MYOMO, ~~to Section 13 or 15(d)~~ INC.

of(Exact ~~the~~name ~~Securities~~of ~~Exchange~~Registrant ~~Act~~as ofSpecified ~~1934~~in Its Charter)

Date of Report (Date of earliest event reported): March 9, 2026


Delaware	001-38109	47-0944526
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

45 Blue Sky Dr. Suite 101
Burlington, Massachusetts		01803
(Address of Principal Executive Offices)		(Zip Code)

~~Myomo~~Registrant’s Telephone Number, ~~Inc.~~Including Area Code: 617 996-9058

~~(Exact Name of Company as Specified in Charter)~~ ,

Delaware	001-38109	47-0944526
(State or Other Jurisdictionof Incorporation)	(CommissionFile Number)	(IRS EmployerIdentification No.)
45 Blue Sky Dr., Suite 101Burlington, MA		01803
(Address of Principal Executive Offices)		(Zip Code)

(Former Name or Former Address, if Changed Since Last Report)

~~Company’s~~Check ~~telephone~~the ~~number,~~appropriate ~~including~~box ~~area~~below ~~code:~~if ~~(617)~~the ~~996~~Form 8-~~9058~~K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~Not~~☐Written ~~applicable~~communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~(Former~~☐Soliciting ~~Name~~material orpursuant ~~Former~~to ~~Address,~~Rule if14a-12 ~~Changed~~under ~~Since~~the ~~Last~~Exchange ~~Report)~~Act (17 CFR 240.14a-12)

~~Check the appropriate box below if the Form 8~~☐Pre-Kcommencement ~~filing~~communications ispursuant ~~intended~~ to ~~simultaneously~~Rule ~~satisfy~~14d-2(b) ~~the filing obligation of the registrant~~ under ~~any of~~ the ~~following~~Exchange ~~provisions~~Act (~~see~~17 ~~General~~CFR ~~Instruction A~~240.14d-2~~. below~~(b): )

☐ ~~Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐~~ Pre-commencement communications pursuant to Rule ~~14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule~~ 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		TradingSymbol(s)		Name of each ~~exchangeon~~exchange on which registered
Common Stock, $0.0001 par value per share		MYO		NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§  230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§  240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.02. Results Departure of OperationsDirectors andor FinancialCertain ConditionOfficers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~March~~April 914, 2026, upon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Myomo, Inc,. (the "Company"), ~~announced~~the ~~its~~Board ~~financial~~appointed ~~results~~William ~~for~~J. ~~the~~Febbo ~~fourth~~to ~~quarter~~join ~~and~~the ~~full~~Board, ~~year~~effective ~~ended~~on ~~December~~April 3114, ~~2025~~2026. ~~The~~Mr. ~~full~~Febbo ~~text~~will ofserve ~~the~~as ~~press~~a ~~release~~Class ~~issued~~II indirector ~~connection~~until ~~with~~his term expires at the ~~announcement~~2028 isannual ~~furnished~~meeting asof ~~Exhibit~~shareholders, 99at which time he will stand for election by the Company’s shareholders.1 toMr ~~this~~Febbo ~~Current~~has ~~Report~~not been appointed to serve on ~~Form~~any ~~8-K~~committees of the Board.

~~The~~Mr. ~~information~~Febbo, in57, ~~this~~currently ~~Form~~serves ~~8-K~~as ~~(including~~Chief ~~Exhibit~~Executive ~~99.1)~~Officer isand ~~intended~~Director toof bePerformance ~~furnished~~Health Systems, a privately-held company that utilizes health and ~~shall~~wellness ~~not~~equipment beto ~~deemed~~improve ~~“filed”~~mobility for ~~purposes~~people ofat ~~Section~~home, 18businesses, ofand ~~the~~clinics, ~~Securities~~which ~~Exchange~~he ~~Act~~joined ofin ~~1934~~February 2026. Previously, he served as ~~amended~~Chief ~~(the~~Executive ~~“Exchange~~Officer ~~Act”),~~of orOptimizeRx ~~otherwise~~Corporation ~~subject~~(NASDAQ: OPRX) from 2015 to 2024. Mr. Febbo has also co-founded and led companies focused on the ~~liabilities~~capital ofmarkets, ~~that~~including ~~section~~Merriman Holdings, ~~nor~~Inc., ~~shall~~and itDigital beCapital ~~deemed~~Network. ~~incorporated~~Mr. byFebbo ~~reference~~holds a BA in ~~any~~International ~~filing~~Studies ~~under~~and ~~the~~Spanish ~~Securities~~from ~~Act~~Dickinson ofCollege. He ~~1933,~~is asan ~~amended,~~MIT-affiliated orfaculty member and mentor in the ~~Exchange~~linQ ~~Act~~program, ~~except~~which assupports ~~expressly~~biomedical ~~set~~innovation ~~forth~~addressing bymajor ~~specific~~health ~~reference~~and inmedical ~~such~~challenges. He also serves as a ~~filing~~Mentor for the X & Y Class at Harvard Business School.

In connection with his appointment to the Board, Mr. Febbo was granted 45,000 restricted stock units ("RSUs"), which will vest in their entirety on the first anniversary of the effective date of his appointment to the Board. As a non-employee director, Mr. Febbo will also receive an annual cash retainer of $60,000. In addition, Mr. Febbo will be entitled to receive $85,000 annually, paid in the form of RSUs, which vest over four quarters .Mr. Febbo is not a party to any transaction with the Company that would require disclosure under Item 9404(a) of Regulation S-K, and there are no arrangements or understandings between Mr.01 Febbo and any other persons pursuant to which he was selected as a director. In addition, Mr. Febbo has entered into an indemnification agreement with the Company consistent with the form of indemnification agreement entered into between the Company and its existing non-employee directors.

(d) ExhibitsItem 7.01 Regulation FD Disclosure.

Exhibit No.		Description
99.1		Press release issued by Myomo, Inc. on March 9, 2026, furnished herewith.
104		The cover page from the Company’s Form 8-K dated March 9, 2026, formatted in Inline XBRL

On April 16, 2026, the Company issued a press release announcing the appointment of Mr. Febbo. A copy of the Company’s press release relating to this announcement is attached as Exhibit 99.1 to this current report on Form 8-K (the “Report”).

~~SIGNATURES~~The information contained in Item 7.01 of this Report and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

PursuantItem to9.01 theFinancial requirementsStatements ofand the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorizedExhibits.

			MYOMO, INC.
Date:	March 9, 2026	By:	/s/ David A. Henry
			David A. HenryChief Financial Officer

(d) Exhibits


Exhibit No.		Description


99.1		Press release issued by Myomo, Inc. on April 16, 2026. furnished herewith.
104		The cover page from the Company’s Form 8-K dated April 16, 2026, formatted in Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			Myomo, Inc.

Date:	April 16, 2026	By:	/s/ David A. Henry
			David A. Henry Chief Financial Officer

Filing Compare · MYOMO, INC.